Method of detecting proBNP with a monoclonal antibody binding to the amino acid 41-46

Details for Australian Patent Application No. 2004235974 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Grol, Michael; Borgya, Anneliese; Seidel, Christoph; Hallermayer, Klaus; Gallusser, Andreas; Klemt, Volker

Agent Davies Collison Cave

Pub. Number AU-B-2004235974

PCT Pub. Number WO2004/099253

Priority 03010591.0 12.05.03 EP

Filing date 12 May 2004

Wipo publication date 18 November 2004

Acceptance publication date 14 February 2008

International Classifications

C07K 16/26 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 14/58 (2006.01) Peptides having more than 20 amino acids

C12N 5/20 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - one of the fusion partners being a B lymphocyte

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

24 November 2005 PCT application entered the National Phase

  PCT publication WO2004/099253 Priority application(s): WO2004/099253

14 February 2008 Application Accepted

  Published as AU-B-2004235974

12 June 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004235981-Imidazopyridine intermediates

2004235971-Isoquinoline-3-carboxylic acid amides and pharmaceutical uses thereof